All In MedTech

Device Trial Radar · NCT05966168

Micra AV Tracking During Exercise Testing

Tracking of Mechanically Sensed Atrial Activity During Exercise Using a Leadless Transcatheter Pacing System

Last checked: Nov 20, 2026Latest source record: Apr 17, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Withdrawn

Status

Withdrawn

Enrollment

0

Actual

Start

May 1, 2024

Primary completion

Nov 2025

Study completion Nov 2025

Sponsor

Lead sponsor
Duke UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jul 28, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Other
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine the effectiveness of the Micra AV 2.0 device during exercise or elevated heart rates. Participation in research studies is voluntary. In this study, participants will already be planned to have a Micra AV 2.0 device implanted. Participants will then undergo treadmill exercise testing and wear a Holter monitor. For each participant, the tracking performance of the Micra AV 2.0 will be evaluated at rest and during exercise. Follow up visits will occur as part of standard of care and each participant will be enrolled in the study for up to 6 months.

Conditions

  • Heart Block AV

Interventions

  • Medtronic Micra AV DeviceDevice

    Participants will already be planned to have a Micra AV 2.0 device implanted. Participants will then undergo treadmill exercise testing and wear a Holter monitor to determine the effectiveness of the Micra AV 2.0 device during exercise or elevated heart rates.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Average tracking index at restTime frame: 6 months
  2. Average tracking index during exerciseTime frame: 6 months
  3. Average tracking index during recoveryTime frame: 6 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Duke University Health System

    Durham, North Carolina

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.